aTYR PHARMA INC Prepaid Expense and Other Assets, Current
aTYR PHARMA INC (ATYR) had Prepaid Expense and Other Assets, Current of $545.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-12.
Discontinued › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2020-05-12
- 2020-03-31: Prepaid Expense and Other Assets, Current $545.00K.
- 2019-12-31: Prepaid Expense and Other Assets, Current $781.00K.
- 2019-09-30: Prepaid Expense and Other Assets, Current $1.08M.
- 2019-06-30: Prepaid Expense and Other Assets, Current $1.47M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2020-03-31 | $545.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $781.00K 10-Q · filed 2020-05-12 |
| 2019-09-30 | $1.08M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.47M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.09M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.26M 10-K · filed 2020-03-26 |
| 2018-09-30 | $1.68M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.67M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.91M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.87M 10-K · filed 2019-03-26 |
| 2017-09-30 | $1.82M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.88M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.85M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.62M 10-K · filed 2018-03-20 |
| 2016-09-30 | $3.12M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.96M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $1.57M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $2.42M 10-K · filed 2017-03-16 |
| 2015-09-30 | $2.58M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $3.22M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $657.00K 10-Q · filed 2015-06-18 |
| 2014-12-31 | $656.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |